honokiol
Botanicalexperimental
Honokiol is a lignan isolated from the bark, seed cones, and leaves of trees belonging to the genus Magnolia. It has been identified as one of the chemical compounds in some traditional Eastern herbal medicines along with magnolol, 4-O-methylhonokiol, and obovatol. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00966953)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHonokiol ↗
Also known as
- honokiol
- honokiol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06566443 | Phase 1 | Aug 31, 2024 | Methodist Cancer Center, Houston, Texas, The University of Texas, Dallas |
| NCT00966953 | Phase 3 | Oct 1, 2007 | Colgate Palmolive |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Colgate Palmolive | For profit | 1 | 1 | 1 | 2007 |
| Methodist Cancer Center, Houston, Texas | Academic/Hospital | 1 | 0 | 1 | 2024 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1